Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
pubmed:
15
9
2020
medline:
18
11
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
Transjugular liver biopsy (TJLB) and hepatic venous pressure gradient (HVPG) measurement are diagnostic procedures for patients with acute and chronic liver diseases. Technical execution of TJLB and HVPG may be challenging in patients with advanced liver disease. We studied consecutive TJLB and HVPG procedures and investigated technical success, complications, quality of biopsies, indications and treatment changes in patients with and without liver cirrhosis. In the study period from 2010 to 2018, 575 consecutive TJLB and HVPG procedures were analyzed. Demographic characteristics, procedure-related and follow-up data were extracted from medical records. In total, 259 (45%) patients were diagnosed with liver cirrhosis whereas 316 (55%) patients had no evidence of advanced chronic liver disease. Technical success of TJLB was significantly higher in patients without liver cirrhosis (287; 92%) compared to patients with liver cirrhosis [184; 76.7% (P = 0.001)]. Technical success of HVPG measurement was not different between both groups (P = 0.553). Liver biopsy specimens were significantly shorter in patients with liver cirrhosis (P = 0.001). Medical therapy was adjusted in 163 (28.4%) patients. In patients with liver cirrhosis, results of TJLB led less frequently to therapy initiation or adjustment compared to patients without liver cirrhosis (P = 0.001). In multivariate analysis, liver cirrhosis (Exp(B) 1.866; P = 0.012), alanine aminotransferase (Exp(B) 0.248; P < 0.001) and INR (Exp(B) 0.583; P = 0.027) were independently associated with treatment change. Technical success and therapeutic decisions of TJLB are directly linked to presence or absence of liver cirrhosis.
Sections du résumé
BACKGROUND
Transjugular liver biopsy (TJLB) and hepatic venous pressure gradient (HVPG) measurement are diagnostic procedures for patients with acute and chronic liver diseases. Technical execution of TJLB and HVPG may be challenging in patients with advanced liver disease.
OBJECTIVE
We studied consecutive TJLB and HVPG procedures and investigated technical success, complications, quality of biopsies, indications and treatment changes in patients with and without liver cirrhosis.
METHODS
In the study period from 2010 to 2018, 575 consecutive TJLB and HVPG procedures were analyzed. Demographic characteristics, procedure-related and follow-up data were extracted from medical records.
RESULTS
In total, 259 (45%) patients were diagnosed with liver cirrhosis whereas 316 (55%) patients had no evidence of advanced chronic liver disease. Technical success of TJLB was significantly higher in patients without liver cirrhosis (287; 92%) compared to patients with liver cirrhosis [184; 76.7% (P = 0.001)]. Technical success of HVPG measurement was not different between both groups (P = 0.553). Liver biopsy specimens were significantly shorter in patients with liver cirrhosis (P = 0.001). Medical therapy was adjusted in 163 (28.4%) patients. In patients with liver cirrhosis, results of TJLB led less frequently to therapy initiation or adjustment compared to patients without liver cirrhosis (P = 0.001). In multivariate analysis, liver cirrhosis (Exp(B) 1.866; P = 0.012), alanine aminotransferase (Exp(B) 0.248; P < 0.001) and INR (Exp(B) 0.583; P = 0.027) were independently associated with treatment change.
CONCLUSION
Technical success and therapeutic decisions of TJLB are directly linked to presence or absence of liver cirrhosis.
Identifiants
pubmed: 32925497
pii: 00042737-202112000-00019
doi: 10.1097/MEG.0000000000001904
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1582-1587Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, et al. Transjugular liver biopsy – indications, adequacy, quality of specimens, and complications – a systematic review. J Hepatol 2007; 47:284–294.
Behrens G, Ferral H. Transjugular liver biopsy. Semin Intervent Radiol 2012; 29:111–117.
Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med 2016; 375:767–777.
D’Amico G, Morabito A, D’Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and competing risks. J Hepatol 2018; 68:563–576.
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44:217–231.
Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 2013; 158:807–820.
Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med 2017; 377:756–768.
Mauro E, Gadano A. What’s new in portal hypertension? Liver Int 2020;40 (Suppl 1):122–127.
Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008;48 (Suppl 1):S68–S92.
Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009; 6:573–582.
La Mura V, Garcia-Guix M, Berzigotti A, et al. A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk-stratification after variceal bleeding. Hepatology. 2020. doi: 10.1002/hep.31125.
doi: 10.1002/hep.31125
Pfeifer L, Zopf S, Siebler J, Schwitulla J, Wildner D, Wachter D, et al. Prospective Evaluation of Acoustic Radiation Force Impulse (ARFI) Elastography and High-Frequency B-Mode Ultrasound in Compensated Patients for the Diagnosis of Liver Fibrosis/Cirrhosis in Comparison to Mini-Laparoscopic Biopsy. Ultraschall Med 2015; 36581–589.
O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445.
Chevallier P, Dausse F, Berthier F, Saint-Paul MC, Denys A, Schnyder P, Bruneton JN. Transjugular liver biopsy: prospective evaluation of the angle formed between the hepatic veins and the vena cava main axis and modification of a semi-automated biopsy device in cases of an unfavorable angle. Eur Radiol 2007; 17:169–173.
Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83:338–340.
Gamble P, Colapinto RF, Stronell RD, Colman JC, Blendis L. Transjugular liver biopsy: a review of 461 biopsies. Radiology 1985; 157:589–593.
Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, et al. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Dig Liver Dis 2019; 51:1144–1151.
Azoulay D, Raccuia JS, Roche B, Reynes M, Bismuth H. The value of early transjugular liver biopsy after liver transplantation. Transplantation 1996; 61:406–409.
Lee KA, Taylor A, Bartolome B, Fidelman N, Kolli KP, Kohi M, et al. Safety and efficacy of transjugular liver biopsy in patients with left lobe-only liver transplants. J Vasc Interv Radiol 2019; 30:1043–1047.
Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993; 18:1370–1376.
Fyfe B, Zaldana F, Liu C. The pathology of acute liver failure. Clin Liver Dis 2018; 22:257–268.
Pievsky D, Rustgi N, Pyrsopoulos NT. Classification and epidemiologic aspects of acute liver failure. Clin Liver Dis 2018; 22:229–241.
Sue MJ, Lee EW, Saab S, McWilliams JP, Durazo F, El-Kabany M, et al. Transjugular liver biopsy: safe even in patients with severe coagulopathies and multiple biopsies. Clin Transl Gastroenterol 2019; 10:e00063.
Ble M, Procopet B, Miquel R, Hernandez-Gea V, García-Pagán JC. Transjugular liver biopsy. Clin Liver Dis 2014; 18:767–778.